BiotechTube
Home/Owl Therapeutics/William Haskins
WH

William Haskins

Co-Founder & CEO

Owl Therapeutics

Therapeutic Areas

NeurologyNeurodegenerative DiseasesTraumatic Brain Injury

Owl Therapeutics Pipeline

DrugIndicationPhase
NeuroSTAT® (OWL-1410)Traumatic Brain Injury (TBI)Pre-clinical
AI-engineered candidatesAlzheimer's DiseasePre-clinical

Leadership Team at Owl Therapeutics

FO
Franklin Okumu
Co-Founder & CTO
HL
Henry Lowman
Co-Founder & Technical Advisor
TK
Todd Kilbaugh
Co-Founder & Clinical Advisor
View full Owl Therapeutics profile